We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SATX.WS.A
3301
CALL
DELISTED
SatixFy Communications Ltd.
SATX.WS.A
-254,838
Closed -$1.98M
LHC
3302
DELISTED
Leo Holdings Corp. II
LHC
-602,940
Closed -$6.08M
ALOR
3303
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
-537,206
Closed -$5.5M
PRPC
3304
DELISTED
CC Neuberger Principal Holdings III
PRPC
-630,995
Closed -$6.37M
AAC
3305
DELISTED
Ares Acquisition Corporation
AAC
-2,674,574
Closed -$26.9M
ITAQ
3306
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
-571,143
Closed -$5.81M
DEN
3307
DELISTED
Denbury Inc.
DEN
-111,205
Closed -$9.68M
TRCA
3308
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
-939,037
Closed -$9.47M
CXAC
3309
DELISTED
C5 Acquisition Corporation
CXAC
-324,785
Closed -$3.32M
HPLT
3310
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
-989,994
Closed -$10M
FSNB
3311
DELISTED
Fusion Acquisition Corp. II
FSNB
-2,416,639
Closed -$24.3M
RAD
3312
DELISTED
Rite Aid Corporation
RAD
-192,369
Closed -$643K
CCV
3313
DELISTED
Churchill Capital Corp V
CCV
-2,106,739
Closed -$20.9M
BIOS
3314
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
-502,350
Closed -$5.16M
FZT
3315
DELISTED
FAST Acquisition Corp. II
FZT
-1,024,548
Closed -$10.3M
LFAC
3316
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
-569,515
Closed -$5.84M
CELL
3317
DELISTED
PhenomeX Inc. Common Stock
CELL
-31,797
Closed -$85.2K
MPRA
3318
DELISTED
Mercato Partners Acquisition Corporation Class A Common Stock
MPRA
-659,474
Closed -$6.77M
SLVRW
3319
CALL
DELISTED
SilverSPAC Inc. Warrant
SLVRW
-13,996
Closed -$140K
ICNC
3320
DELISTED
Iconic Sports Acquisition Corp.
ICNC
-1,430,668
Closed -$14.8M
GFGD
3321
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
-1,062,210
Closed -$10.7M
PRTK
3322
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-43,952
Closed -$82.2K
NSTD
3323
DELISTED
Northern Star Investment Corp. IV
NSTD
-1,834,634
Closed -$18.4M
RTL
3324
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
-80,784
Closed -$479K
SURF
3325
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-110,928
Closed -$91K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.